Invention Grant
- Patent Title: TTC8 as prognostic gene for progressive retinal atrophy in dogs
-
Application No.: US14404291Application Date: 2013-05-24
-
Publication No.: US09752195B2Publication Date: 2017-09-05
- Inventor: Cathryn Suzanne Mellersh , Louise Mary Downs
- Applicant: Animal Health Trust
- Applicant Address: GB Newmarket
- Assignee: Animal Health Trust
- Current Assignee: Animal Health Trust
- Current Assignee Address: GB Newmarket
- Agency: McDermott Will & Emery LLP
- Agent Judy Mohr
- Priority: GB1209420.7 20120528
- International Application: PCT/GB2013/051365 WO 20130524
- International Announcement: WO2013/179001 WO 20131205
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12Q1/68
Abstract:
The invention relates to the use of the TTC8 gene as a biomarker for the prognosis of a canine mammal developing progressive retinal atrophy. The invention also relates to in vitro methods of prognosing progressive retinal atrophy in a canine mammal by detecting a genetic variation within the TTC8 gene and to primers and prognostic kits for use in said method.
Public/Granted literature
- US20150148406A1 TTC8 AS PROGNOSTIC GENE FOR PROGRESSIVE RETINAL ATROPHY IN DOGS Public/Granted day:2015-05-28
Information query
